Dacryocystorhinostomy is a surgical procedure for restoring patency of the nasolacrimal duct.
To make this complex medical term easier to understand, let us break it down and translate each of its components from Greek — "creation of a new opening between the lacrimal sac and the nasal cavity."
"Dacryo-" (from Greek dakryon) — means "tear".
"Cysto-" (from Greek kystis) — means "sac" (referring to the lacrimal sac).
"Rhino-" (from Greek rhis) — means "nose".
"-stomy" (from Greek stoma) — means "opening" or "anastomosis".
Dacryocystorhinostomy requires strict medical indications.
It is prescribed when other treatment methods have not produced the desired effect. This procedure is often required as a consequence of repeated probing, when damage to the nasolacrimal duct is already such that it cannot be restored. Nasolacrimal duct conditions are most common in newborns and in elderly patients.
Crystal Vision's inpatient facility treats both newborns and adults.
First, working with newborns who have already undergone previous interventions demands a truly delicate approach. Conventional dacryocystorhinostomy is highly traumatic. For this reason, we use only an innovative approach — performing endoscopic treatment, under safe anaesthesia, using a diamond microdrill, in one of the finest inpatient facilities in central Moscow.
The surgeon makes a small opening in the bone through the nostril, and then, under monitor-guided visual control, passes the mucosa of the upper portions of the nasolacrimal duct through this opening from above. This mucosa effectively fuses with the nasal mucosa, forming a shared anastomosis. A stent is then inserted from above and removed after 2–2.5 months. The procedure is minimally traumatic, unlike conventional, outdated methods, and its effectiveness approaches 100%.
No incisions or scars are left on the skin of the face.
The same minimally traumatic approach is used for surgical treatment in adults.
All available in a single lacrimal pathway treatment package — DAVS DACRYO care!
